Barclays analyst Jason Goldberg lowered the firm’s price target on Comerica to $49 from $52 and keeps an Underweight rating on the shares. While the company’s Q3 results were ahead of estimates, results in Q4 are expected to be marred by a reaccelerating decline in net interest income, lower fees, and another increase in expenses, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on CMA: